392 related articles for article (PubMed ID: 16403414)
21. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1.
Li L; Krantz ID; Deng Y; Genin A; Banta AB; Collins CC; Qi M; Trask BJ; Kuo WL; Cochran J; Costa T; Pierpont ME; Rand EB; Piccoli DA; Hood L; Spinner NB
Nat Genet; 1997 Jul; 16(3):243-51. PubMed ID: 9207788
[TBL] [Abstract][Full Text] [Related]
22. Mutational analysis of the Jagged 1 gene in Alagille syndrome families.
Yuan ZR; Kohsaka T; Ikegaya T; Suzuki T; Okano S; Abe J; Kobayashi N; Yamada M
Hum Mol Genet; 1998 Sep; 7(9):1363-9. PubMed ID: 9700188
[TBL] [Abstract][Full Text] [Related]
23. Gene symbol: JAG1. Disease: Alagille syndrome.
Conidi ME; Michelucci A; Maggiore G; Simi P
Hum Genet; 2008 Oct; 124(3):321-2. PubMed ID: 18846680
[No Abstract] [Full Text] [Related]
24. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome.
Hofmann JJ; Zovein AC; Koh H; Radtke F; Weinmaster G; Iruela-Arispe ML
Development; 2010 Dec; 137(23):4061-72. PubMed ID: 21062863
[TBL] [Abstract][Full Text] [Related]
25. Novel human pathological mutations. Gene symbol: JAG1. Disease: Alagille syndrome.
Marchetti D; Iascone MR; Pezzoli L
Hum Genet; 2009 Aug; 126(2):344-5. PubMed ID: 19694039
[No Abstract] [Full Text] [Related]
26. Biological function of mutant forms of JAGGED1 proteins in Alagille syndrome: inhibitory effect on Notch signaling.
Boyer-Di Ponio J; Wright-Crosnier C; Groyer-Picard MT; Driancourt C; Beau I; Hadchouel M; Meunier-Rotival M
Hum Mol Genet; 2007 Nov; 16(22):2683-92. PubMed ID: 17720887
[TBL] [Abstract][Full Text] [Related]
27. The DSL domain in mutant JAG1 ligand is essential for the severity of the liver defect in Alagille syndrome.
Yuan ZR; Okaniwa M; Nagata I; Tazawa Y; Ito M; Kawarazaki H; Inomata Y; Okano S; Yoshida T; Kobayashi N; Kohsaka T
Clin Genet; 2001 May; 59(5):330-7. PubMed ID: 11359464
[TBL] [Abstract][Full Text] [Related]
28. Jagged1 (JAG1): Structure, expression, and disease associations.
Grochowski CM; Loomes KM; Spinner NB
Gene; 2016 Jan; 576(1 Pt 3):381-4. PubMed ID: 26548814
[TBL] [Abstract][Full Text] [Related]
29. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency.
McCright B; Lozier J; Gridley T
Development; 2002 Feb; 129(4):1075-82. PubMed ID: 11861489
[TBL] [Abstract][Full Text] [Related]
30. The significance of human jagged 1 mutations detected in severe cases of extrahepatic biliary atresia.
Kohsaka T; Yuan ZR; Guo SX; Tagawa M; Nakamura A; Nakano M; Kawasasaki H; Inomata Y; Tanaka K; Miyauchi J
Hepatology; 2002 Oct; 36(4 Pt 1):904-12. PubMed ID: 12297837
[TBL] [Abstract][Full Text] [Related]
31. Variable expression of Alagille syndrome in a family with a new JAG1 gene mutation.
Ziesenitz VC; Loukanov T; Gläser C; Gorenflo M
Cardiol Young; 2016 Jan; 26(1):164-7. PubMed ID: 25613755
[TBL] [Abstract][Full Text] [Related]
32. An autosomal recessive form of Alagille-like syndrome that is not linked to JAG1.
Dyack S; Cameron M; Otley A; Greer W
Genet Med; 2007 Aug; 9(8):544-50. PubMed ID: 17700393
[TBL] [Abstract][Full Text] [Related]
33. Novel human pathological mutations. Gene symbol: JAG1. Disease: Alagille syndrome.
Marchetti D; Iascone MR; Pezzoli L
Hum Genet; 2009 Aug; 126(2):345. PubMed ID: 19694043
[No Abstract] [Full Text] [Related]
34. Inhibition of Jagged-mediated Notch signaling disrupts zebrafish biliary development and generates multi-organ defects compatible with an Alagille syndrome phenocopy.
Lorent K; Yeo SY; Oda T; Chandrasekharappa S; Chitnis A; Matthews RP; Pack M
Development; 2004 Nov; 131(22):5753-66. PubMed ID: 15509774
[TBL] [Abstract][Full Text] [Related]
35. PKCδ is required for Jagged-1 induction of human mesenchymal stem cell osteogenic differentiation.
Zhu F; Sweetwyne MT; Hankenson KD
Stem Cells; 2013 Jun; 31(6):1181-92. PubMed ID: 23404789
[TBL] [Abstract][Full Text] [Related]
36. Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients.
Colliton RP; Bason L; Lu FM; Piccoli DA; Krantz ID; Spinner NB
Hum Mutat; 2001 Feb; 17(2):151-2. PubMed ID: 11180599
[TBL] [Abstract][Full Text] [Related]
37. ASO silencing of a glycosyltransferase, Poglut1 , improves the liver phenotypes in mouse models of Alagille syndrome.
Niknejad N; Fox D; Burwinkel JL; Zarrin-Khameh N; Cho S; Soriano A; Cast AE; Lopez MF; Huppert KA; Rigo F; Huppert SS; Jafar-Nejad P; Jafar-Nejad H
Hepatology; 2023 Nov; 78(5):1337-1351. PubMed ID: 37021797
[TBL] [Abstract][Full Text] [Related]
38. Clinical and molecular genetics of Alagille syndrome.
Krantz ID; Piccoli DA; Spinner NB
Curr Opin Pediatr; 1999 Dec; 11(6):558-64. PubMed ID: 10590916
[TBL] [Abstract][Full Text] [Related]
39. Novel human pathological mutations. Gene symbol: JAG1. Disease: Alagille syndrome.
Marchetti D; Iascone MR; Pezzoli L
Hum Genet; 2009 Aug; 126(2):349-50. PubMed ID: 19694054
[No Abstract] [Full Text] [Related]
40. Novel human pathological mutations. Gene symbol: JAG1. Disease: Alagille syndrome.
Marchetti D; Iascone MR; Pezzoli L
Hum Genet; 2009 Aug; 126(2):347-8. PubMed ID: 19694049
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
